What is the recommended phenytoin dosing regimen for children with epilepsy?

Phenytoin Dosing for Pediatric Epilepsy

For children with epilepsy, initiate phenytoin at 5 mg/kg/day divided into 2-3 doses, with maintenance dosing typically 4-8 mg/kg/day (maximum 300 mg/day), though infants under 3 months may require substantially higher doses of 10-20 mg/kg/day to achieve therapeutic levels. 1

Age-Specific Dosing Considerations

Neonates and Young Infants (<3 months)

• Neonates require 10 mg/kg as the initial IV loading dose (lower than older children due to increased toxicity risk from decreased protein binding) 2
• For oral maintenance in infants under 3 months, doses of 10-20 mg/kg/day are required to achieve therapeutic serum concentrations, considerably higher than adult requirements 3
• Phenobarbital is preferred over phenytoin in neonates due to the increased risk of toxicity with phenytoin 2
• Free phenytoin levels in infants are 8-13% of total serum concentrations, similar to adults 3

Children and Adolescents

• Initial dosing: 5 mg/kg/day divided into 2-3 equally divided doses 1
• Maintenance dosing: 4-8 mg/kg/day (maximum 300 mg daily) 1
• Children over 6 years and adolescents may require the minimum adult dose of 300 mg/day 1
• Twice-daily dosing is recommended as single daily dosing produces inadequate serum levels 16-24 hours after ingestion 4

Status Epilepticus Dosing

IV Loading Dose

• Children: 20 mg/kg IV (maximum initial dose: 1000 mg) 2
• Neonates: 10 mg/kg IV 2
• Infusion rate: not to exceed 1 mg/kg/min over 10-20 minutes 2
• May repeat dose once if necessary after 15 minutes (maximum total dose: 40 mg/kg) 2

Critical Safety Considerations for IV Administration

• Dilute in normal saline only—phenytoin is incompatible with glucose-containing solutions and will precipitate 2
• Monitor heart rate continuously—reduce infusion rate if heart rate decreases by 10 beats per minute 2
• Risk of hypotension and arrhythmias, especially with rapid infusion 2
• Fosphenytoin is preferred when available due to lower risk of adverse cardiac effects 2
• Be prepared to provide respiratory support—increased incidence of apnea when combined with other sedative agents 2

Therapeutic Monitoring

Target Serum Levels

• Therapeutic range: 10-20 mcg/mL 1
• Time to steady state: 7-10 days in most patients 1
• Important exception: Children previously taking phenobarbital may require 1-4 weeks to achieve phenytoin equilibrium (10 of 13 children in one study) 4

Monitoring Recommendations

• Do not adjust dosage at intervals shorter than 7-10 days unless clinically urgent 1
• Serum level monitoring is essential when switching between formulations (sodium salt vs. free acid form) due to approximately 8% difference in drug content 1
• Weight estimation errors are common and clinically significant—using estimated weights resulted in patients receiving 78-138% of expected dose, with 20% developing supra-therapeutic levels >20 mcg/mL 5

Formulation-Specific Considerations

Extended-Release Capsules (Dilantin)

• Once-daily dosing (300 mg) may be considered only in adults with established seizure control on divided doses 1
• Once-daily dosing is NOT recommended for children or for other phenytoin formulations due to differences in dissolution characteristics 1

Suspension and Chewable Tablets

• Shake suspension bottles well before dispensing—twice-daily dosing produces satisfactory serum levels when properly mixed 4
• These formulations contain the free acid form rather than sodium salt, requiring dose adjustment considerations 1

Common Pitfalls to Avoid

• Avoid single daily dosing in children—produces inadequate serum levels throughout the 24-hour period 4
• Never use glucose-containing IV solutions—will cause precipitation 2
• Do not use adult loading doses in neonates—use 10 mg/kg, not 20 mg/kg 2
• Account for prior phenobarbital use—delays phenytoin equilibrium significantly 4
• Use actual weights when possible—estimated weights led to dosing errors of up to 138% of intended dose 5